Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPARα Agonist Fenofibrate-Treated Mice

Fenofibrate (FBR), an oral medication used to treat dyslipidemia, is a ligand of the peroxisome proliferator-activated receptor α (PPARα), a nuclear receptor that regulates the expression of metabolic genes able to control lipid metabolism and food intake. PPARα natural ligands include fatty acids (...

Full description

Bibliographic Details
Main Authors:	Elisabetta Murru, Anna Lisa Muntoni, Claudia Manca, Sonia Aroni, Marco Pistis, Sebastiano Banni, Gianfranca Carta
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	International Journal of Molecular Sciences
Subjects:	fenofibrate peroxisome proliferator-activated receptor α (PPARα) lipid metabolism n3-highly unsaturated fatty acid (HUFA) score endocannabinoids <i>N</i>-acylethanolamines
Online Access:	https://www.mdpi.com/1422-0067/24/1/709

Similar Items

PPARα Signaling: A Candidate Target in Psychiatric Disorder Management
by: Simona Scheggi, et al.
Published: (2022-05-01)

Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders
by: Claudia Sagheddu, et al.
Published: (2021-10-01)

Systemic Changes in Endocannabinoids and Endocannabinoid-like Molecules in Response to Partial Nephrectomy-Induced Ischemia in Humans
by: Ariel Rothner, et al.
Published: (2023-02-01)

Indirect Calorimetry-Based Novel Approach for Evaluating Metabolic Flexibility and Its Association with Circulating Metabolic Markers in Middle-Aged Subjects
by: Elisabetta Murru, et al.
Published: (2024-02-01)

Effect of fenofibrate and selective PPARα modulator (SPPARMα), pemafibrate on KATP channel activity and insulin secretion
by: Shigeki Kitamura, et al.
Published: (2023-09-01)

Fatty Acid Metabolism and Derived-Mediators Distinctive of PPAR-α Activation in Obese Subjects Post Bariatric Surgery
by: Claudia Manca, et al.
Published: (2021-12-01)

The Expanded Endocannabinoid System Contributes to Metabolic and Body Mass Shifts in First-Episode Schizophrenia: A 5-Year Follow-Up Study
by: Madis Parksepp, et al.
Published: (2022-01-01)

Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation
by: Ludmila A. Kasatkina, et al.
Published: (2021-05-01)

Oleoylethanolamide attenuates acute-to-chronic kidney injury: in vivo and in vitro evidence of PPAR-α involvement
by: Federica Comella, et al.
Published: (2024-02-01)

Fenofibrate suppresses corneal neovascularization by regulating lipid metabolism through PPARα signaling pathway
by: Tong Zhou, et al.
Published: (2022-12-01)

Disease-Specific Derangement of Circulating Endocannabinoids and <i>N</i>-Acylethanolamines in Myeloproliferative Neoplasms
by: Dorian Forte, et al.
Published: (2020-05-01)

Anti-inflammatory role of fenofibrate in treating diseases
by: Lv Jin, et al.
Published: (2023-05-01)

PPARα agonist fenofibrate prevents postoperative cognitive dysfunction by enhancing fatty acid oxidation in mice
by: Liu Tiantian, et al.
Published: (2023-11-01)

Modulation of Endocannabinoid Tone in Osteoblastic Differentiation of MC3T3-E1 Cells and in Mouse Bone Tissue over Time
by: Magdalena Kostrzewa, et al.
Published: (2021-05-01)

Activation of PPARα by Fenofibrate Attenuates the Effect of Local Heart High Dose Irradiation on the Mouse Cardiac Proteome
by: Omid Azimzadeh, et al.
Published: (2021-12-01)

Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide?
by: Giorgia della Rocca, et al.
Published: (2021-03-01)

A Fenofibrate Diet Prevents Paclitaxel-Induced Peripheral Neuropathy in Mice
by: Martial Caillaud, et al.
Published: (2020-12-01)

Fenofibrate inhibits TGF‐β‐induced myofibroblast differentiation and activation in human lung fibroblasts in vitro
by: Ryota Kikuchi, et al.
Published: (2021-08-01)

Levels of bioactive endogenous lipids and health-related quality of life in Chronic Idiopathic Axonal Polyneuropathy
by: Jonas Lind, et al.
Published: (2022-05-01)

Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate
by: Akihiro Honda, et al.
Published: (2022-04-01)

Circulating Endocannabinoids and N-Acylethanolamines in Individuals with Cannabis Use Disorder—Preliminary Findings
by: Nadia Boachie, et al.
Published: (2023-09-01)

Effect of fenofibrate on brain infarction, brain swelling and edema in focal-transient cerebral ischemia in rat
by: Hadi Vahidi, et al.
Published: (2021-10-01)

Oleamide activates peroxisome proliferator-activated receptor gamma (PPARγ) <it>in vitro</it>
by: Dionisi Mauro, et al.
Published: (2012-05-01)

The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation
by: Fabio Arturo Iannotti, et al.
Published: (2021-03-01)

Curcumin promotes AApoAII amyloidosis and peroxisome proliferation in mice by activating the PPARα signaling pathway
by: Jian Dai, et al.
Published: (2021-01-01)

Peroxisomal Fitness: A Potential Protective Mechanism of Fenofibrate against High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
by: Songling Jiang, et al.
Published: (2022-11-01)

Pleiotropic effects of PPAR-α – from benchside to bedside
by: I. V. Shirinsky, et al.
Published: (2021-06-01)

Therapeutic Effects of Fenofibrate Nano-Emulsion Eye Drops on Retinal Vascular Leakage and Neovascularization
by: Li Huang, et al.
Published: (2021-12-01)

Fenofibrate Regulates Visceral Obesity and Nonalcoholic Steatohepatitis in Obese Female Ovariectomized C57BL/6J Mice
by: Yujin Shin, et al.
Published: (2021-04-01)

CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
by: V. S. Shirinsky, et al.
Published: (2017-05-01)

Efficacy and Safety of Fenofibrate in Patients with Hyperuricemia
by: Irfan Zafar, et al.
Published: (2012-04-01)

Efficacy and Safety of Fenofibrate in Patients with Hyperuricemia
by: Irfan Zafar, et al.
Published: (2012-04-01)

Therapeutic effect of fenofibrate for non-alcoholic steatohepatitis in mouse models is dependent on regime design
by: Xinxue Wang, et al.
Published: (2023-05-01)

Influence of partial substitution of dietary marine origin feedstuffs by a mixture of extruded pea seed meal and animal origin feedstuffs on fatty acid composition of fillet in sea bass (Dicentrarchus labrax)
by: Manuel Scerra, et al.
Published: (2016-10-01)

Activation of PPARα Ameliorates Cardiac Fibrosis in Dsg2-Deficient Arrhythmogenic Cardiomyopathy
by: Zirui Qiu, et al.
Published: (2022-10-01)

The Basal Pharmacology of Palmitoylethanolamide
by: Linda Rankin, et al.
Published: (2020-10-01)

Role of fenofibrate in multiple sclerosis
by: Ahmad A. Abulaban, et al.
Published: (2024-02-01)

Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα
by: Mounia Tahri-Joutey, et al.
Published: (2021-08-01)

Fatty acid composition of juvenile abalone (Haliotis tuberculata coccinea) fed formulated diets containing various n3 HUFA levels
by: PH Toledo-Agüero, et al.
Published: (2009-03-01)

Fatty acid composition of juvenile abalone (Haliotis tuberculata coccinea) fed formulated diets containing various n3 HUFA levels
by: PH Toledo-Agüero, et al.
Published: (2009-03-01)